415 related articles for article (PubMed ID: 29128090)
1. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
Christodoulou E; Kadoglou NPE; Stasinopoulou M; Konstandi OA; Kenoutis C; Kakazanis ZI; Rizakou A; Kostomitsopoulos N; Valsami G
Atherosclerosis; 2018 Jan; 268():207-214. PubMed ID: 29128090
[TBL] [Abstract][Full Text] [Related]
2. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Nasiri-Ansari Ν; Dimitriadis GK; Agrogiannis G; Perrea D; Kostakis ID; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Cardiovasc Diabetol; 2018 Jul; 17(1):106. PubMed ID: 30049285
[TBL] [Abstract][Full Text] [Related]
3. A thioredoxin-mimetic peptide exerts potent anti-inflammatory, antioxidant, and atheroprotective effects in ApoE2.Ki mice fed high fat diet.
Canesi F; Mateo V; Couchie D; Karabina S; Nègre-Salvayre A; Rouis M; El Hadri K
Cardiovasc Res; 2019 Feb; 115(2):292-301. PubMed ID: 30010817
[TBL] [Abstract][Full Text] [Related]
4. Saffron (Crocus sativus) intake provides nutritional preconditioning against myocardial ischemia-reperfusion injury in Wild Type and ApoE
Efentakis P; Rizakou A; Christodoulou E; Chatzianastasiou A; López MG; León R; Balafas E; Kadoglou NPE; Tseti I; Skaltsa H; Kostomitsopoulos N; Iliodromitis EK; Valsami G; Andreadou I
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):919-929. PubMed ID: 28964663
[TBL] [Abstract][Full Text] [Related]
5. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
[TBL] [Abstract][Full Text] [Related]
6. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
8. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice.
Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946
[TBL] [Abstract][Full Text] [Related]
9. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
[TBL] [Abstract][Full Text] [Related]
10. Statins' Withdrawal Induces Atherosclerotic Plaque Destabilization in Animal Model-A "Rebound" Stimulation of Inflammation.
Stasinopoulou M; Kadoglou NPE; Christodoulou E; Paronis E; Kostomitsopoulos NG; Valsami G; Liapis CD; Kakisis J
J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):377-386. PubMed ID: 30905179
[TBL] [Abstract][Full Text] [Related]
11. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
12. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
[TBL] [Abstract][Full Text] [Related]
13. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
[TBL] [Abstract][Full Text] [Related]
14. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
15. Food supplementation with rice bran enzymatic extract prevents vascular apoptosis and atherogenesis in ApoE-/- mice.
Perez-Ternero C; Herrera MD; Laufs U; Alvarez de Sotomayor M; Werner C
Eur J Nutr; 2017 Feb; 56(1):225-236. PubMed ID: 26476632
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
18. The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
Li S; Wang K; Xu G; Ji J; Qin C
Pak J Pharm Sci; 2016 Nov; 29(6):1907-1912. PubMed ID: 28375105
[TBL] [Abstract][Full Text] [Related]
19. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
[TBL] [Abstract][Full Text] [Related]
20. LongShengZhi Capsule Reduces Established Atherosclerotic Lesions in apoE-Deficient Mice by Ameliorating Hepatic Lipid Metabolism and Inhibiting Inflammation.
Ma J; Zhao D; Wang X; Ma C; Feng K; Zhang S; Chen Y; Zhu Y; Gao X; Zhao B; Wang Y; Qian K; Li X; Duan Y; Han J; Yang X
J Cardiovasc Pharmacol; 2019 Feb; 73(2):105-117. PubMed ID: 30540683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
